期刊论文详细信息
Bratislava Medical Journal
Comparison of inflammation markers with prediction scores in patients with community-acquired pneumonia
article
E. Acar1  H. Gokcen1  A. Demir1  B. Yildirim1 
[1]Mugla Sitki Kocman University, Faculty of Medicine, Department of Emergency Medicine
关键词: community-acquired pneumonia;    respiratory tract infection;    prediction scores;    lymphocyte to CRP ratio;    systemic immune-inflammation index;    mortality;   
DOI  :  10.4149/BLL_2021_069
学科分类:医学(综合)
来源: AEPress, s.r.o.
PDF
【 摘 要 】
OBJECTIVE: The lymphocyte-to-C-reactive protein ratio (LCRP) and Systemic Immune-Inflammation Index (SII) can successfully predict 28-day mortality rates with community-acquired pneumonia METHODS: This prospective study was conducted in 2018. Hospitalized patients underwent follow-up evaluations 28 days after admission. RESULTS: A total of 345 patients with CAP were enrolled in this study. All-cause mortality at the 28th day of follow-up was 13.6 %. There were statistically significant results between the 2 groups (survivors and non-survivors), in terms of the LCRP, SII, PSI, and CURB-65 values. Moreover, the optimal LCRP cutoff for predicting 28-day mortality was determined to be 4, with 89 % sensitivity, 73 % specificity. Based on the average SII>3551for predicting 28-day mortality, the sensitivity, specificity was 63.8 %, 68.1 % respectively. When the value of the cutoff PSI was ≥130 points, the sensitivity, specificity was 68 %, 65 %, respectively. Based on 3 points and above as the cutoff value of the CURB-65 score, the sensitivity, specificity was 80 %, 68 %, respectively. ROC curve analysis revealed that the areas of LCRP, SII, PSI, and CURB-65 under the AUC in terms of 28-day mortality were 0,820,0,737,681, and 0,773, respectively, CONCLUSIONS: LCRP and SII level are valuable for predicting the mortality rate among patients with CAP at ED admission (Tab. 3, Fig. 3, Ref. 27).
【 授权许可】

CC BY   

【 预 览 】
附件列表
Files Size Format View
RO202302200001268ZK.pdf 262KB PDF download
  文献评价指标  
  下载次数:0次 浏览次数:0次